Skip to main content

Table 2 Prevalence of bacterial and viral pathogens among HIV-positive and HIV-negative African-Caribbean women in Toronto

From: The epidemiology of sexually transmitted co-infections in HIV-positive and HIV-negative African-Caribbean women in Toronto

 

HIV-positive

HIV-negative

p value

 

Tested

Positive

Prevalence % (95% CIa)

Tested

Positive

Prevalence % (95% CI)

 

Chlamydia

123

0

0.0% (0.0-2.9%

286

11

3.8% (1.9-6.8%)

0.039b

Gonorrhea

124

0

0.0% (0.0-2.9%)

285

0

0.0% (0.0-1.3%)

NS

Syphilis

126

1

0.79% (0.02-4.3%)

291

1

0.34% (0.01-1.9%)

NS

Bacterial vaginosis

123

19

15.4% (9.6-23.1%)

283

49

17.3% (13.1-22.2%)

NS

Abnormal vaginal flora

123

42

34.1% (25.8-43.2%)

283

84

29.7% (24.4-35.4%)

NS

Trichomonas vaginalis

124

9

7.3% (3.4-13.3%)

286

13

4.5% (2.4-7.6%)

NS

Yeast

123

9

7.3% (3.3-13.4%)

283

19

6.7% (4.1-10.3%)

NS

HSV-1

123

111

90.2% (83.6-94.6%)

290

254

87.6% (83.2-91.2%)

NS

HSV-2

124

107

86.3% (79.0-91.8%)

290

135

46.6% (40.7-52.5%)

<0.0001

Cytomegalovirus

126

125

99.2% (95.7-100%)

291

274

94.2% (90.8-96.6%)

0.018

High risk HPV, vaginal

124

60

48.4% (39.3-57.5%

283

49

17.3% (12.9-21.7%

<0.0001

HCV

126

5

4.0% (1.3-9.0%)

290

4

1.4% (0.38-3.5%)

NS

HBV infectedc

126

6

4.8% (1.8-10.1%)

291

1

0.34% (0.01-1.9%)

0.004b

HBV everd

126

60

47.6% (38.7-56.7%)

283

60

21.2% (16.6-26.4%)

<0.0001

HBV vaccination

109

72

66.1% (56.4-74.9%)

248

109

44.0% (37.7-50.4%)

0.0001

  1. a95% exact binomial confidence interval.
  2. bFisher’s Exact Test.
  3. cInfected with HBV: HBsAg, with or without other HBV markers.
  4. dEver infected with HBV: HBsAg, anti-HBc, or anti-HBs if not vaccinated for HBV.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us